跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,676 条关于
“GIP/GLP-1”
全部
64,676
临床试验
39,922
药物
7,850
机构
1,456
资讯
15,448
去年
Hengrui and Kailera Present Phase 2 Data for Dual GLP-1/GIP Agonist and Oral GLP-1 Therapies at ADA 2025
去年
Retatrutide Shows Promising Weight Loss Results Compared to Other GLP-1 Agonists
上个月
Eli Lilly Launches Legal Challenges Against Tirzepatide Generics
去年
Palatin Technologies Completes Enrollment in Phase 2 Obesity Trial of Bremelanotide and Tirzepatide Combination
去年
Wegovy Shows 57% Greater Cardiovascular Risk Reduction Compared to Tirzepatide in Real-World Study
上个月
Neurocrine Biosciences Launches Phase I Trial of GLP-1/GIP/Glucagon Triple Agonist NBIP-1968 for Obesity
3年前
Approved Anti-Obesity Medications in 2022: A Comprehensive Overview
去年
Palatin Technologies Completes Enrollment in Phase 2 Obesity Trial of Bremelanotide with Tirzepatide
去年
Intensity Therapeutics and Fractyl Health Advance Clinical Programs in Oncology and Metabolic Disease
去年
American Heart Association Awards $1M to Study GLP-1 Medications' Impact on Cardiovascular Risk
第 1 页,共 1545 页
上一页
下一页